This session will explore the pathophysiology of respiratory depression due to opioid administration, identifying high-risk patients, and the respiratory therapist’s role in patient monitoring and prevention of opioid-induced respiratory depression.
Successful completion of this course requires a score of 70% on the post-test.
This webcast is sponsored in part by an unrestricted educational grant from Covidien.
Discuss the pathophysiology of respiratory depression due to opioid administration.
Identify high risk patients for respiratory depression due to opioid administration.
Identify the respiratory therapist’s role in patient monitoring and prevention of opioid-induced respiratory depression.